Nutritional Approaches to Modulate Cardiovascular Disease Risk in Systemic Lupus Erythematosus: A Literature Review
暂无分享,去创建一个
Mónica R. Meza-Meza | I. Parra-Rojas | U. de la Cruz-Mosso | M. Montoya-Buelna | Karen Pesqueda-Cendejas | Bertha Campos-López | Melissa Rivera-Escoto
[1] A. Kalea,et al. Diet and Systemic Lupus Erythematosus (SLE): From Supplementation to Intervention , 2022, International journal of environmental research and public health.
[2] Minjian Kong,et al. Systemic Lupus Erythematosus and Cardiovascular Disease: A Mendelian Randomization Study , 2022, Frontiers in Immunology.
[3] B. Szponar,et al. Serum levels of n-3 and n-6 polyunsaturated fatty acids in patients with systemic lupus erythematosus and their association with disease activity: a pilot study , 2021, Scandinavian journal of rheumatology.
[4] N. Žarković,et al. Oxidative Stress and Lipid Mediators Modulate Immune Cell Functions in Autoimmune Diseases , 2021, International journal of molecular sciences.
[5] J. Muñóz-Valle,et al. Association of cardiometabolic risk status with clinical activity and damage in systemic lupus erythematosus patients: A cross-sectional study. , 2020, Clinical immunology.
[6] S. Rahman,et al. LOX-1: A potential driver of cardiovascular risk in SLE patients , 2020, PloS one.
[7] D. Ye,et al. Serum/plasma homocysteine levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis , 2020, Clinical Rheumatology.
[8] D. Nikolopoulos,et al. Cardiovascular Disease in Systemic Lupus Erythematosus: recent data on epidemiology, risk factors and prevention. , 2019, Current vascular pharmacology.
[9] M. Garaulet,et al. Relationship of Excess Weight with Clinical Activity and Dietary Intake Deficiencies in Systemic Lupus Erythematosus Patients , 2019, Nutrients.
[10] M. Bäck,et al. The resolution of inflammation through omega-3 fatty acids in atherosclerosis, intimal hyperplasia, and vascular calcification , 2019, Seminars in Immunopathology.
[11] M. Hosseinzadeh‐Attar,et al. Effects of Selenium Supplementation on Asymmetric Dimethylarginine and Cardiometabolic Risk Factors in Patients with Polycystic Ovary Syndrome , 2019, Biological Trace Element Research.
[12] W. Tissing,et al. Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia , 2019, PloS one.
[13] C. Ruiz,et al. Vitamin D and autoimmune diseases. , 2019, Life sciences.
[14] A. Ruiz-Arguelles,et al. Systemic lupus erythematosus and hypertension. , 2019, Autoimmunity reviews.
[15] Tianfu Wu,et al. Elevated oxidized lipids, anti-lipid autoantibodies and oxidized lipid immune complexes in active SLE. , 2019, Clinical immunology.
[16] R. Manno,et al. Hyperhomocysteinemia and Lupus Nephritis , 2019, Cureus.
[17] C. Mok. Metabolic syndrome and systemic lupus erythematosus: the connection , 2019, Expert review of clinical immunology.
[18] A. La Cava. The Influence of Diet and Obesity on Gene Expression in SLE , 2019, Genes.
[19] D. Bonaduce,et al. Inflammatory, Serological and Vascular Determinants of Cardiovascular Disease in Systemic Lupus Erythematosus Patients , 2019, International journal of molecular sciences.
[20] Dahai Yu,et al. Impact of antimalarial (AM) on serum lipids in systemic lupus erythematosus (SLE) patients , 2019, Medicine.
[21] N. Olsen,et al. Selenium supplementation suppresses immunological and serological features of lupus in B6.Sle1b mice , 2019, Autoimmunity.
[22] L. Trupin,et al. Racial/Ethnic Differences in Prevalence of and Time to Onset of SLE Manifestations: The California Lupus Surveillance Project (CLSP). , 2019, Arthritis care & research.
[23] T. Desai,et al. Pro-resolving lipid mediators in vascular disease. , 2018, The Journal of clinical investigation.
[24] H. Moutsopoulos,et al. Contribution of MTHFR gene variants in lupus related subclinical atherosclerosis. , 2018, Clinical immunology.
[25] Yeonseok Chung,et al. Dyslipidemia promotes germinal center reactions via IL-27 , 2018, BMB Reports.
[26] Ahmed Rebai,et al. Association of hyperhomocysteinemia with genetic variants in key enzymes of homocysteine metabolism and methotrexate toxicity in rheumatoid arthritis patients , 2018, Inflammation Research.
[27] G. Lima,et al. C-reactive protein (CRP) polymorphisms and haplotypes are associated with SLE susceptibility and activity but not with serum CRP levels in Mexican population , 2018, Clinical Rheumatology.
[28] K. Elmusharaf,et al. Effect of Gum Arabic (Acacia Senegal) supplementation on visceral adiposity index (VAI) and blood pressure in patients with type 2 diabetes mellitus as indicators of cardiovascular disease (CVD): a randomized and placebo-controlled clinical trial , 2018, Lipids in Health and Disease.
[29] A. Afeltra,et al. Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus , 2018, PloS one.
[30] A. Mangoni,et al. Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus , 2018, Mediators of inflammation.
[31] Y. Shoenfeld,et al. Antiphospholipid syndrome , 2018, Nature Reviews Disease Primers.
[32] J. Rosa,et al. Homocysteine, folate, hs-C-reactive protein, tumor necrosis factor alpha and inflammatory proteins: are these biomarkers related to nutritional status and cardiovascular risk in childhood-onset systemic lupus erythematosus? , 2018, Pediatric Rheumatology.
[33] W. Ling,et al. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals. , 2017, Journal of clinical lipidology.
[34] S. N. Murthy,et al. The metabolism and significance of homocysteine in nutrition and health , 2017, Nutrition & Metabolism.
[35] Y. Shoenfeld,et al. Vitamin D and Autoimmune Diseases , 2017 .
[36] F. Wilson,et al. Exercise and physical activity in systemic lupus erythematosus: A systematic review with meta-analyses. , 2017, Seminars in arthritis and rheumatism.
[37] C. Mavragani,et al. Cardiovascular disease in systemic lupus erythematosus: A comprehensive update. , 2017, Journal of autoimmunity.
[38] Anisur Rahman,et al. Atherosclerosis in systemic lupus erythematosus. , 2017, Best practice & research. Clinical rheumatology.
[39] R. Hegele,et al. Functional foods and dietary supplements for the management of dyslipidaemia , 2017, Nature Reviews Endocrinology.
[40] R. Pandey,et al. Effects of 3 g of soluble fiber from oats on lipid levels of Asian Indians - a randomized controlled, parallel arm study , 2017, Lipids in Health and Disease.
[41] M. Sánchez-Hidalgo,et al. An update on diet and nutritional factors in systemic lupus erythematosus management , 2017, Nutrition Research Reviews.
[42] P. Szodoray,et al. Dyslipidemia in systemic lupus erythematosus , 2017, Immunologic Research.
[43] E. Lubberts,et al. Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential , 2017, Front. Immunol..
[44] M. Mansuri,et al. Association of Neuropeptide-Y (NPY) and Interleukin-1beta (IL1B), Genotype-Phenotype Correlation and Plasma Lipids with Type-II Diabetes , 2016, PloS one.
[45] C. Torp-Pedersen,et al. Incidence of Systemic Lupus Erythematosus and Lupus Nephritis in Denmark: A Nationwide Cohort Study , 2016, The Journal of Rheumatology.
[46] D. Ray,et al. Vitamin D improves endothelial dysfunction and restores myeloid angiogenic cell function via reduced CXCL-10 expression in systemic lupus erythematosus , 2016, Scientific Reports.
[47] Caroline Gordon,et al. The frequency and outcome of lupus nephritis: results from an international inception cohort study. , 2016, Rheumatology.
[48] M. Wigren,et al. Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention , 2015, Journal of internal medicine.
[49] F. Dall’ara,et al. Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D , 2015, Lupus.
[50] B. Jortner,et al. Paradoxical Effects of All-Trans-Retinoic Acid on Lupus-Like Disease in the MRL/lpr Mouse Model , 2015, PloS one.
[51] R. Cecchini,et al. Fish Oil N-3 Fatty Acids Increase Adiponectin and Decrease Leptin Levels in Patients with Systemic Lupus Erythematosus , 2015, Marine drugs.
[52] J. Asara,et al. Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin , 2015, Metabolomics.
[53] M. Mahmoudi,et al. Assessment of 1,25-dihydroxyvitamin D3 effects on Treg cells in a mouse model of systemic lupus erythematosus , 2015, Immunopharmacology and immunotoxicology.
[54] Hong Zhou,et al. Involvement of TLR4 in oxidized LDL/β2GPI/anti-β2GPI-induced transformation of macrophages to foam cells. , 2014, Journal of atherosclerosis and thrombosis.
[55] Y. Shoenfeld,et al. Obesity in autoimmune diseases: not a passive bystander. , 2014, Autoimmunity reviews.
[56] A. Saboor-Yaraghi,et al. Vitamin A Supplementation Reduces IL‐17 and RORc Gene Expression in Atherosclerotic Patients , 2014, Scandinavian journal of immunology.
[57] M. Kivimaki,et al. Combined effect of physical activity and leisure time sitting on long-term risk of incident obesity and metabolic risk factor clustering , 2014, Diabetologia.
[58] N. Costedoat-Chalumeau,et al. Hydroxychloroquine: a multifaceted treatment in lupus. , 2014, Presse medicale.
[59] D. Bikle,et al. Vitamin D metabolism, mechanism of action, and clinical applications. , 2014, Chemistry & biology.
[60] A. Sawalha,et al. Diet influences expression of autoimmune-associated genes and disease severity by epigenetic mechanisms in a transgenic mouse model of lupus. , 2013, Arthritis and rheumatism.
[61] Simone Appenzeller,et al. Risk Factors in Cardiovascular Disease in Systemic Lupus Erythematosus , 2013, Current cardiology reviews.
[62] M. Correia,et al. Excess weight and associated risk factors in patients with systemic lupus erythematosus , 2013, Rheumatology International.
[63] M. Correia,et al. Nutritional status and food intake in patients with systemic lupus erythematosus. , 2012, Nutrition.
[64] D. Greco,et al. Leptin-Induced mTOR Activation Defines a Specific Molecular and Transcriptional Signature Controlling CD4+ Effector T Cell Responses , 2012, The Journal of Immunology.
[65] Stephen V Faraone,et al. N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. , 2012, Arthritis and rheumatism.
[66] B. Illades-Aguiar,et al. Common variants in the CRP gene are associated with serum C-reactive protein levels and body mass index in healthy individuals in Mexico. , 2012, Genetics and molecular research : GMR.
[67] S. Azar,et al. Effect of lysine, vitamin B(6), and carnitine supplementation on the lipid profile of male patients with hypertriglyceridemia: a 12-week, open-label, randomized, placebo-controlled trial. , 2012, Clinical therapeutics.
[68] Shigeru Inoue,et al. The pandemic of physical inactivity: global action for public health , 2012, The Lancet.
[69] T. Gheita,et al. The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis , 2012, International journal of rheumatic diseases.
[70] W. Callaghan,et al. Hypertension in Women of Reproductive Age in the United States: NHANES 1999-2008 , 2012, PloS one.
[71] E. Bonfá,et al. Diet and nutritional aspects in systemic lupus erythematosus. , 2012, Revista brasileira de reumatologia.
[72] J. Manson,et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. , 2012, Contemporary clinical trials.
[73] J. Kuk,et al. Relation of physical activity to cardiovascular disease mortality and the influence of cardiometabolic risk factors. , 2011, The American journal of cardiology.
[74] B. Hahn,et al. Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention , 2011, Expert review of clinical immunology.
[75] M. Kaplan,et al. The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus , 2011, Arthritis research & therapy.
[76] P. Menheere,et al. Safety and T Cell Modulating Effects of High Dose Vitamin D3 Supplementation in Multiple Sclerosis , 2010, PloS one.
[77] J. Coombes,et al. Omega-3 polyunsaturated fatty acids in the treatment of kidney disease. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[78] S. Kardia,et al. Sex difference in the association of metabolic syndrome with high sensitivity C-reactive protein in a Taiwanese population , 2010, BMC public health.
[79] B. Chandrasekar,et al. Docosahexaenoic Acid-Enriched Fish Oil Attenuates Kidney Disease and Prolongs Median and Maximal Life Span of Autoimmune Lupus-Prone Mice , 2010, The Journal of Immunology.
[80] J. Pestka. n-3 polyunsaturated fatty acids and autoimmune-mediated glomerulonephritis. , 2010, Prostaglandins, leukotrienes, and essential fatty acids.
[81] M. Ward,et al. Nephritis and the risk of acute myocardial infarction in patients with systemic lupus erythematosus. , 2010, Clinical and experimental rheumatology.
[82] Z. Fayad,et al. Associations between plasma C-reactive protein levels and the severities of coronary and aortic atherosclerosis. , 2010, Journal of atherosclerosis and thrombosis.
[83] A. Kuryliszyn-Moskal,et al. Analysis of correlations between selected endothelial cell activation markers, disease activity, and nailfold capillaroscopy microvascular changes in systemic lupus erythematosus patients , 2010, Clinical Rheumatology.
[84] Stampfer,et al. Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study. , 2009, Arthritis and rheumatism.
[85] D. Panagiotakos,et al. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. , 2008, Arthritis and rheumatism.
[86] P. Raggi,et al. Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus. , 2008, The Journal of rheumatology.
[87] J. Manson,et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. , 2008, JAMA.
[88] S. Appenzeller,et al. Cardiovascular Disease in Systemic Lupus Erythematosus: The Role of Traditional and Lupus Related Risk Factors , 2008, Current cardiology reviews.
[89] E. McCarthy,et al. Obesity and C‐reactive Protein Levels Among White, Black, and Hispanic US Adults , 2008, Obesity.
[90] M. Abrahamowicz,et al. Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus? , 2008, Arthritis and rheumatism.
[91] I. Bruce,et al. Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. , 2008, Arthritis and rheumatism.
[92] G. McVeigh,et al. A randomised interventional trial of ω-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus , 2007, Annals of the rheumatic diseases.
[93] P. Jacques,et al. In vitamin B12 deficiency, higher serum folate is associated with increased total homocysteine and methylmalonic acid concentrations , 2007, Proceedings of the National Academy of Sciences.
[94] H. Stangl,et al. Cholesterol efflux via HDL resecretion occurs when cholesterol transport out of the lysosome is impaireds⃞ Published, JLR Papers in Press, July 9, 2007. , 2007, Journal of Lipid Research.
[95] P. Low,et al. Depletion of folate-receptor-positive macrophages leads to alleviation of symptoms and prolonged survival in two murine models of systemic lupus erythematosus. , 2007, Molecular pharmaceutics.
[96] C. Sandborg,et al. Review: Management of dyslipidemia in children and adolescents with systemic lupus erythematosus , 2007 .
[97] T. Matsuo,et al. Uremic hyperhomocysteinemia: A randomized trial of folate treatment for the prevention of cardiovascular events , 2007, Hemodialysis international. International Symposium on Home Hemodialysis.
[98] P. Raggi,et al. High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors , 2006, Annals of the rheumatic diseases.
[99] H. Otani,et al. The efficacy of vitamin E against oxidative damage and autoantibody production in systemic lupus erythematosus: a preliminary study , 2007, Clinical Rheumatology.
[100] C. Stein,et al. Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus. , 2005, Arthritis and rheumatism.
[101] V. Lee,et al. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study. , 2005, The Journal of rheumatology.
[102] Victoria Moreno-Manzano,et al. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease. , 2004, Kidney international.
[103] J. Strain,et al. The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus. , 2004, The Journal of rheumatology.
[104] G. Fernandes,et al. Food Restriction and Fish Oil Suppress Atherogenic Risk Factors in Lupus-Prone (NZB × NZW) F1 Mice , 2004, Journal of Clinical Immunology.
[105] A. Leibovitz,et al. Anemia, serum vitamin B12, and folic acid in patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus , 2004, Rheumatology International.
[106] L. Klareskog,et al. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus. , 2003, Arthritis and rheumatism.
[107] C. Gordon,et al. Cardiovascular risk in systemic lupus erythematosus--evidence of increased oxidative stress and dyslipidaemia. , 2003, Rheumatology.
[108] Yuji Nozaki,et al. Retinoic Acid Reduces Autoimmune Renal Injury and Increases Survival in NZB/W F1 Mice , 2003, The Journal of Immunology.
[109] Y. Minami,et al. Diet and systemic lupus erythematosus: a 4 year prospective study of Japanese patients. , 2003, The Journal of rheumatology.
[110] B. Meyer,et al. Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids , 2003, Lipids.
[111] Peter Eck,et al. Vitamin C as an Antioxidant: Evaluation of Its Role in Disease Prevention , 2003, Journal of the American College of Nutrition.
[112] G. Jahreis,et al. Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol , 2002, European Journal of Clinical Nutrition.
[113] W. Hörl,et al. Influence of mycophenolic acid and tacrolimus on homocysteine metabolism. , 2002, Kidney international.
[114] M. Petri. Diet and systemic lupus erythematosus: from mouse and monkey to woman? , 2001, Lupus.
[115] D. Brady,et al. Natural medicine and nutritional therapy as an alternative treatment in systemic lupus erythematosus. , 2001, Alternative medicine review : a journal of clinical therapeutic.
[116] F. Formiga,et al. Lipid and lipoprotein levels in premenopausal systemic lupus erythematosus patients , 2001, Lupus.
[117] A. Leiba,et al. Diet and lupus , 2001, Lupus.
[118] A. Brown. Lupus erythematosus and nutrition: a review of the literature. , 2000, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[119] L. Adorini,et al. 1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation , 2000, The Journal of Immunology.
[120] R. D'Agostino,et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. , 1997, American journal of epidemiology.
[121] D. Troyer,et al. Dietary Omega-3 Lipids Delay the Onset and Progression of Autoimmune Lupus Nephritis by Inhibiting Transforming Growth Factor β mRNA and Protein Expression , 1995 .
[122] B. Weimann,et al. Effects of Antioxidant Vitamins C, E, and β‐Carotene on Immune Functions in MRL/Ipr Mice and Rats , 1992 .
[123] J. Lemire,et al. 1,25-Dihydroxyvitamin D3 Attenuates of Expression of Experimental Murine Lupus of MRL/1 Mice , 1992 .